Assessment of Hematological Disorders in Patients Using Phenytoin With or Without Nutritional Supplements
DOI:
https://doi.org/10.37591/rrjom.v5i3.1496Abstract
Phenytoin is the most prescribed drug in controlling the epileptic seizures for prolonged period and this can lead to life-threatening adverse events. This prospective study is aimed to find out the incidence of hematological disorders (HDs) in patients receiving Phenytoin. The authors have screened 100 patients receiving phenytoin for ≥ 6 months, of whom 35 were recruited as per the eligibility criteria and their hematological parameters were noted, 90% of patients have developed anemia and the remaining 10% have developed other HDs. Patients receiving Phenytoin along with the IFA alone, both IFA and BC have shown better HB values (11.25 g/dL) than patients receiving B-complex alone (9.68 g/dL) and the authors have assessed the nutritional status of the study subjects and found 67% patients were well nourished. Incidence of Phenytoin-induced hematological diseases; especially anemia was observed in most of the patients, co-prescription of nutritional supplements in combination of folic acid along with Phenytoin will diminish the incidence of Phenytoin-induced hematological disorders. Regular and periodical monitoring of hematological parameters of patients under Phenytoin therapy for long-term period is necessary for early identification and management of HDs.
Keywords: Phenytoin, hematological disorders, nutritional supplements, folic acid, anemia
Cite this Article
Venkata Subbaiah Meda, Anjum Beparie Bushrah, Naik Sabavath Omkar et al. Assessment of hematological disorders in patients using phenytoin with or without nutritional supplements. Research and Reviews: Journal of Medicine. 2015; 5(3): 1–5p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |